Neuberger Berman Group »

Heron Therapeutics shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $17k 39k 0.43
2018-06-30 $1.0M 27k 38.87

More positions owned by Neuberger Berman Group

Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Microsoft Corp Common (MSFT)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Jpmorgan Chase & Co Common (JPM)
Eli Lilly & Co Common (LLY)
Ishares Core S&p 500 Etf Etf (IVV)
Broadcom Common (AVGO)
Asml Holding Adr Representing Nv Common (ASML)
Meta Platforms Inc Class A A Common (META)
Home Depot Common (HD)
Nextera Energy Common (NEE)
Analog Devices Common (ADI)

View all positions for Neuberger Berman Group

Top funds holding Heron Therapeutics

Rubric Capital Management
Clearline Capital
BlackRock
Velan Capital Investment Management
Vanguard Capital Management
Tejara Capital
Tang Capital Management
Geode Capital Management
Millennium Management
State Street Corporation
JW Asset Management
Caption Management
UBS Group
Pale Fire Capital SE
Marshall Wace

View all funds holding Heron Therapeutics